Showing results (671-680 of 711) with videos related to
Sort By:
Pageof 72
Immunity & Ageing : I & A|September 19, 2019
Immunosenescence and human vaccine immune responsesStephen N Crooke, Inna G Ovsyannikova, Gregory A Poland, et al.Immunity & Ageing : I & A|August 26, 2016
The inflammatory protein Pentraxin 3 in cardiovascular diseaseFrancesco Fornai, Albino Carrizzo, Maurizio Forte, et al.Immunity & Ageing : I & A|April 15, 2021
An evaluation of the recognised systemic inflammatory biomarkers of chronic sub-optimal inflammation provides evidence for inflammageing (IFA) during multiple sclerosis (MS)Christopher BoltonImmunity & Ageing : I & A|April 13, 2021
Analysis of the heterogeneity of the BCR H-CDR3 repertoire in the bone marrow and spleen of 3-, 12-, and 20-month old miceLina Ma, Xinxin Tao, Xiaoyan He, et al.Immunity & Ageing : I & A|December 30, 2025
Neutrophil-to-lymphocyte ratio as a sex-specific predictor of short-term mortality in hospitalised older adults with COVID-19: a pragmatic biomarker of inflammaging in acute vulnerabilityChiara Ceolin, Veronica Liberati, Vittorio Acunto, et al.Immunity & Ageing : I & A|April 18, 2020
Can an effective SARS-CoV-2 vaccine be developed for the older population?Graham Pawelec, Nan-Ping WengImmunity & Ageing : I & A|November 17, 2022
The diseased kidney: aging and senescent immunologyMingxuan Chi, Zijun Tian, Kuai Ma, et al.Immunity & Ageing : I & A|July 20, 2022
Evaluation of T-cell aging-related immune phenotypes in the context of biological aging and multimorbidity in the Health and Retirement StudyRamya Ramasubramanian, Helen C S Meier, Sithara Vivek, et al.Immunity & Ageing : I & A|May 17, 2023
Targeting the hallmarks of aging to improve influenza vaccine responses in older adultsAndreia N Cadar, Dominique E Martin, Jenna M BartleyImmunity & Ageing : I & A|August 18, 2020
COVID-19: age, Interleukin-6, C-reactive protein, and lymphocytes as key clues from a multicentre retrospective studyAurora Jurado, María C Martín, Cristina Abad-Molina, et al.Pageof 72